Business Context and Reporting Period
This Form 8-K is a current report filed by Silexion Therapeutics Corp on August 20, 2025. The registrant is incorporated in the Cayman Islands with principal executive offices in Ramat-Gan, Israel. The report primarily addresses the implementation of a 1-for-15 reverse share split and the subsequent retroactive adjustment of prior financial statements.
Key Financial Metrics
The filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity for the current period. The document focuses on the structural adjustment of share counts and per-share data rather than reporting new operational financial results.
- Reverse Share Split: 1-for-15 ratio.
- Effective Date: July 28, 2025.
- Trading Resumption: July 29, 2025, on the Nasdaq Capital Market.
- Securities Affected: Ordinary Shares (SLXN) and Warrants (SLXNW).
Material Changes Versus Prior Period
The primary material change is the retroactive adjustment of the Company's audited financial statements for the year ended December 31, 2024. These statements have been updated to reflect the reduced number of ordinary shares and the increased share price resulting from the reverse share split. The 2024 financials originally reflected results from Silexion Therapeutics Ltd. (the predecessor) from January 1, 2024, through August 15, 2024.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the share split mechanics. The document notes that the updated 2024 financial statements are attached as Exhibit 99.1 and incorporated by reference.
Investor Verification Checklist
- Verify the updated share count and per-share metrics in the attached Exhibit 99.1 (Updated 2024 Financials).
- Confirm the adjusted exercise price of outstanding warrants (SLXNW) following the 1-for-15 split.
- Review the 2024 audited financial statements to ensure all historical data has been correctly restated for the reverse split.
- Check current trading volume and price stability on the Nasdaq Capital Market post-split.